New research offers more evidence linking targeted therapies for patients with advanced renal cell carcinoma to higher risks for major adverse cardiovascular events.
The two groups had similar gender, age and socioeconomic levels. Combined, the groups were 74% male, the median age was 63, and 68% hadAfter stabilized inverse probability of treatment weighting, the adjusted incidence rates of major cardiovascular events were 6.65 and 3.36 per 100 person-years in the targeted and cytokine therapy groups, respectively."The higher cardiovascular risk of the targeted group was driven primarily by the VEGFR TKI–treated patients," the authors wrote.
Two drugs were linked to statistically significant higher rates of major cardiovascular adverse events compared with the reference drug=.021) and the mTOR temsirolimus . Sunitinib was by far the most commonly used targeted therapy drug. Among patients on targeted therapy, several factors were linked to higher rates of major cardiovascular events, such as baseline history of
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
DMTs Significantly Cut Risk of Long-Term Disability in PPMSTreatment with disease-modifying therapies is linked to a significantly reduced risk of becoming wheelchair dependent over 10 years – but only in primary progressive MS or with inflammatory activity.
Read more »
FDA Okays First Targeted Agent for HER2-Low Breast CancerThe targeted therapy led to longer progression-free and overall survival compared with chemotherapy.
Read more »
EPA warns of elevated cancer risk linked to medical sterilization facilities in Lakewood, other communitiesThe Environmental Protection Agency on Wednesday said it plans to do outreach to communities where there are elevated cancer risks — including Lakewood — because of medical sterilization facilities that use ethylene oxide in their operations.
Read more »
The Risk of Second Primary Cancer After Prostate RadiotherapyMen with localized prostatecancer that is treated with radiotherapy have a small but statistically elevated risk for a second primary cancer. OncTwitter
Read more »
People of color see delays when seeking radiation treatment, U. study saysPeople of color are experiencing significant delays when they try to obtain a more targeted and effective form of radiation therapy, according to a University of Utah study released Friday.
Read more »